Varenicline for smoking cessation
| Status: |
History |
| Expected date of issue: |
July 2007 |
| Wave: |
12 |
| Process: |
STA |
Topic area:
-
Mental health and behavioural conditions
-
Public health
-
Therapeutic procedures
|
NICE project team
| Executive Lead: |
Andrew Dillon
|
| Technical Lead: |
Prashanth Kandaswamy
|
| Communications manager: |
Tonya Gillis
|
| Project manager: |
Christopher Feinmann
|
|
Evidence review group:
|
School of Health & Related Research Sheffield |
Provisional schedule
| Closing date for invited submissions / evidence submission: |
17 January 2007 |
| Final scope published: |
November 2006 |
| 1st appraisal committee meeting: |
18 April 2007 |
| 2nd appraisal committee meeting |
TBC |
Consultees and Commentators
|
| Consultees |
Commentators (no right of appeal) |
|
Manufacturers / Sponsors
Patient / Carer Groups
- Action Heart
- ASH – Action on Smoking Health
- British Cardiac Patients Association
- British Lung Foundation
- Cancerbackup
- Diabetes UK
- Heart UK
- Macmillan Cancer Relief
- National Cancer Alliance
- National Heart Forum
- Pharmacy HealthLink
- QUIT
- Roy Castle Lung Cancer Foundation
- Specialised Healthcare Alliance
Professional Groups
- Association of Cancer Physicians
- British Association for Nursing in Cardiac Care
- British Cardiac Society
- British Cardiovascular Intervention Society
- British Dental Association
- British Heart Foundation
- British Hypertension Society
- British Psychosocial Oncology Society
- British Thoracic Society
- Cancer Research UK
- General Practice Airways Group
- National Lung Cancer Forum for Nurses
- Primary Care Cardiovascular Society
- RoyalCollegeof Anaesthetists
- RoyalCollegeof General Practitioners
- RoyalCollegeof Midwives
- Royal College of Nursing
- RoyalCollegeof Obstetricians and Gynaecologists
- RoyalCollegeof Pathologists
- RoyalCollegeof Physicians
- RoyalCollege of Physicians of Edinburgh
- RoyalCollegeof Radiologists
- RoyalCollegeof Surgeons
- Royal Pharmaceutical Society
- Society for Cardiological Science and Technology
- Society of Cardiothoracic Surgeons
Others
- Burnley, Pendle and Rossendale PCT
- Department of Health
- Harrow PCT
- Welsh Assembly Government
|
General
- Board of Community Health Councils in Wales
- British National Formulary
- Department of Health, Social Services and Public Safety for Northern Ireland
- Medicines and Healthcare products Regulatory Agency (MHRA)
- National Public Health Service for Wales
- NHS Confederation
- NHS Purchasing and Supply Agency
- NHS Quality Improvement Scotland
- Scottish Medicines Consortium
Comparator Manufacturers
- GlaxoSmithKline (Bupropion)
- GlaxoSmithKline Consumer Healthcare (Nicotine)
- Novartis Consumer Health (Nicotine)
- Pfizer (Nicorette)
Evidence Review Groups
- National Coordinating Centre for Health Technology Assessment
- Schoolof Health and Related Research (ScHARR), University of Sheffield
Associated Guideline Groups
Associated Public Health Groups
Research Groups
- Action on Addiction
- British Society for Cardiovascular Research
- British Thoracic Oncology Group
- Centre for Research on Drugs and Health Behaviour
- Department of Addictive Behaviour and Psychological Medicine (St George?s Hospital Medical School)
- Heart Research UK
- Instituteof CancerResearch
- Instituteof Psychiatry
- Lung and Asthma Information Agency
- National Addiction Centre
- National Cancer Research Institute
- Society for the Study of Addiction
|
|
Project history
| Date |
Update |
| 25 August 2006 |
This topic was referred by the Department of Health and the Welsh Assembly Government as part of the Institute's 12th wave work programme. |
| 3 November 2006 |
List of consultees and commentators published. |
|
Key documents
|
|
|
This page was last updated: 30 May 2007 |
